Nucleating sterile inflammatory cues
Nature Immunology
July 1, 2013
Aggregates of intracellular crystals or peptides, which lead to various inflammatory diseases, are formed from precursors that activate innate immune cells via the receptor CD36 to produce inflammatory mediators.The findings, reported this week in Nature Immunology, point to CD36 as a potential therapeutic target in autoinflammatory diseases.
Inflammatory diseases, including atherosclerosis, Alzheimer’s disease and type 2 diabetes, are triggered by formation of intracellular crystals or peptide fibrils.Kathryn Moore and colleagues show CD36, a surface receptor, activates two signaling arms in response to oxidized low-density lipoprotein (LDL), a molecule that carries cholesterol in blood. Innate immune cells that express CD36 capture and internalize LDL and its cargo of cholesterol. Accumulation of cholesterol leads to its crystal formation and rupture of intracellular vesicles that triggers inflammasome activation. CD36 forms a signaling complex with other receptors that initiate inflammatory gene expression. Mice lacking CD36 expression fail to develop atherosclerosis when fed high-fat diets.
doi: 10.1038/ni.2639
Research highlights
-
Dec 4
Archaeology: Palaeolithic sea voyage to Japanese islands beyond the horizonScientific Reports
-
Dec 3
Ageing: Cellular rejuvenation restores vision in miceNature
-
Dec 1
Neurodegenerative disease: Two blood molecules may predict Alzheimer’s disease developmentNature Aging
-
Nov 27
Archaeology: Neanderthal thumbs better adapted to holding tools with handlesScientific Reports
-
Nov 26
Evolution: Ancient bird sticks its big beak into the evolutionary recordNature
-
Nov 26
Metabolism: Link between SARS-CoV-2 infection and cholesterol hints at COVID-19 treatment possibilitiesNature Metabolism
